Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 4
2010 3
2013 2
2014 1
2015 2
2016 1
2017 1
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. Vergote I, et al. N Engl J Med. 2010 Sep 2;363(10):943-53. doi: 10.1056/NEJMoa0908806. N Engl J Med. 2010. PMID: 20818904 Free article. Clinical Trial.
[The role of laparoscopy in ovarian carcinoma].
Angioli R, Muzii L, Battista C, Terranova C, Oronzi I, Sereni MI, De Oronzo MA, Damiani P, Collettini F, Graziano M, Benedetti Panici P. Angioli R, et al. Among authors: sereni mi. Minerva Ginecol. 2009 Feb;61(1):35-43. Minerva Ginecol. 2009. PMID: 19204659 Review. Italian.
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.
Baldelli E, Hodge KA, Bellezza G, Shah NJ, Gambara G, Sidoni A, Mandarano M, Ruhunusiri C, Dunetz B, Abu-Khalaf M, Wulfkuhle J, Gallagher RI, Liotta L, de Bono J, Mehra N, Riisnaes R, Ravaggi A, Odicino F, Sereni MI, Blackburn M, Zupa A, Improta G, Demsko P, Crino' L, Ludovini V, Giaccone G, Petricoin EF, Pierobon M. Baldelli E, et al. Among authors: sereni mi. J Immunother Cancer. 2021 Oct;9(10):e002179. doi: 10.1136/jitc-2020-002179. J Immunother Cancer. 2021. PMID: 34620701 Free PMC article.
Update on lymphadenectomy in early and advanced ovarian cancer.
Angioli R, Plotti F, Palaia I, Calcagno M, Montera R, Cafà EV, Sereni MI, Panici PB. Angioli R, et al. Among authors: sereni mi. Curr Opin Obstet Gynecol. 2008 Feb;20(1):34-9. doi: 10.1097/GCO.0b013e3282f2fd68. Curr Opin Obstet Gynecol. 2008. PMID: 18197003 Review.
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
Sereni MI, Baldelli E, Gambara G, Ravaggi A, Hodge KA, Alberts DS, Guillen-Rodriguez JM, Dong T, Memo M, Odicino F, Angioli R, Liotta LA, Pecorelli SL, Petricoin EF, Pierobon M. Sereni MI, et al. Br J Cancer. 2017 Aug 8;117(4):494-502. doi: 10.1038/bjc.2017.195. Epub 2017 Jun 29. Br J Cancer. 2017. PMID: 28664915 Free PMC article.
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.
Sereni MI, Baldelli E, Gambara G, Deng J, Zanotti L, Bandiera E, Bignotti E, Ragnoli M, Tognon G, Ravaggi A, Meani F, Memo M, Angioli R, Liotta LA, Pecorelli SL, Petricoin E 3rd, Pierobon M. Sereni MI, et al. Proteomics. 2015 Jan;15(2-3):365-73. doi: 10.1002/pmic.201400214. Proteomics. 2015. PMID: 25311472
14 results